View PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

Read More

View PHARMExcel supports recruitment of the first patient into INmuneBio’s pivotal MDS study showing promising results

PHARMExcel supports recruitment of the first patient into INmuneBio’s pivotal MDS study showing promising results

Read More

View Initial covboost study data ready for analysis..

Initial covboost study data ready for analysis..

Read More

View PHARMExcel running MDS trial that sees first patient treated

PHARMExcel running MDS trial that sees first patient treated

Read More

View Covid: Bradford NHS consultant first in world to receive booster vaccine

Covid: Bradford NHS consultant first in world to receive booster vaccine

Read More

View UK records zero Covid daily deaths as scientists warn of third wave

UK records zero Covid daily deaths as scientists warn of third wave

Read More

View PHARMExcel to support trial delivery of world-first Covid-19 vaccine booster study.

PHARMExcel to support trial delivery of world-first Covid-19 vaccine booster study.

PHARMExcel is delighted to be announced as the UK Contract Research Organisation (CRO) supporting University Hospital Southampton in the delivery of a world-first Covid-19 vaccine booster study. The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at University Hospital Southampton, University Hospitals Dorset and the Portsmouth Research…

Read More

View Sanofo-GSK vaccine showing positive Phase II data

Sanofo-GSK vaccine showing positive Phase II data

Read More

View Increasing confidence jabs work against Indian variant

Increasing confidence jabs work against Indian variant

Read More

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5